Skip to main content

CITADEL ADVISORS LLC

Position in CATX — Perspective Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in CATX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$14,872,320
+$14,128,470 QoQ
Shares Held
3,566,504
+1218.5% QoQ
Ownership
3.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CATX Over Time

Shares Held

Position Value (USD)

Derivatives in CATX

reported options exposure · as of Mar 31, 2026
CallValue
$262,710
CallShares
63,000
PutValue
$44,619
PutShares
10,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,870,022,683 across 83 Medical Devices names. CATX ranks #21 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CATX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $262,710 63,000
2026-03-31 $14,872,320 3,566,504
2026-03-31 $44,619 10,700
2025-12-31 $743,850 270,491
2025-12-31 $151,250 55,000
2025-09-30 $44,933 13,100
2025-09-30 $551,067 160,661
2025-06-30 $59,856 17,400
2025-06-30 $152,942 44,460
2025-03-31 $25,986 12,200
2025-03-31 $21,300 10,000
2025-03-31 $1,082,226 508,088
2024-12-31 $84,216 26,400
2024-12-31 $143,550 45,000
2024-12-31 $685,141 214,778
2024-09-30 $160,520 12,024
2024-09-30 $38,715 2,900
2024-09-30 $25,365 1,900
2024-06-30 $5,738,223 575,549